Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of 9.62% is 108% above its 5-year average of -123.58%, near the high end of its 5-year range (-15988.05%–46.22%).
25.05% above its 12-month average of 7.69%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): -11.19%.
OPERATING MARGIN
9.62%
OPERATING MARGIN AVG TTM
7.69%
OPERATING MARGIN AVG 3Y
-15.05%
OPERATING MARGIN AVG 5Y
-123.58%
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+25.05%
CURRENT VS 3Y AVG
+163.94%
CURRENT VS 5Y AVG
+107.78%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 384 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Market Cap
$2.06B
Operating Margin
38.98%
TTM Avg
19.21%
3Y Avg
-11.92%
5Y Avg
-190.31%
Market Cap
$2.05B
Operating Margin
6.02%
TTM Avg
5.04%
3Y Avg
-2.01%
5Y Avg
-12.30%
Market Cap
$2.11B
Operating Margin
10.04%
TTM Avg
9.32%
3Y Avg
8.61%
5Y Avg
7.98%
Market Cap
$2.02B
Operating Margin
37.06%
TTM Avg
17.54%
3Y Avg
-25.09%
5Y Avg
-117.46%
Market Cap
$2.01B
Operating Margin
0.41%
TTM Avg
-3.56%
3Y Avg
0.15%
5Y Avg
-1.31%
Market Cap
$2.00B
Operating Margin
-5.12%
TTM Avg
-2.62%
3Y Avg
-10.04%
5Y Avg
-13.46%
Market Cap
$2.17B
Operating Margin
-19160.00%
TTM Avg
-10969.44%
3Y Avg
-7268.29%
5Y Avg
-5243.17%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Alvotech (ALVO) | $2.07B | 9.62% | 7.69% | -15.05% | -123.58% |
| BioCryst Pharmaceuticals, Inc. (BCRX)vs › | $2.06B | 38.98% | 19.21% | -11.92% | -190.31% |
| Inspire Medical Systems, Inc. (INSP)vs › | $2.05B | 6.02% | 5.04% | -2.01% | -12.30% |
| Addus HomeCare Corporation (ADUS)vs › | $2.11B | 10.04% | 9.32% | 8.61% | 7.98% |
| Aurinia Pharmaceuticals Inc. (AUPH)vs › | $2.02B | 37.06% | 17.54% | -25.09% | -117.46% |
| Fortrea Holdings Inc. (FTRE)vs › | $2.01B | 0.41% | -3.56% | 0.15% | -1.31% |
| AxoGen, Inc. (AXGN)vs › | $2.00B | -5.12% | -2.62% | -10.04% | -13.46% |
| Azenta, Inc. (AZTA)vs › | $1.97B | -3.49% | -3.57% | -5.95% | -5.03% |
| Celldex Therapeutics, Inc. (CLDX)vs › | $2.17B | -19160.00% | -10969.44% | -7268.29% | -5243.17% |
| Establishment Labs Holdings Inc. (ESTA)vs › | $1.96B | -18.48% | -24.30% | -28.12% | -27.55% |
Gross Margin
60.5%
Operating Margin
9.6%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | -11.19% |
| 2026-03-31 | 9.06% |
| 2025-12-31 | 28.98% |
| 2025-09-30 | 1.19% |
| 2025-06-30 | 10.42% |
| 2025-03-31 | 7.97% |
| 2024-12-31 | 8.91% |
| 2024-09-30 | 12.37% |
| 2024-06-30 | 46.22% |
| 2024-03-31 | -131.39% |
| 2023-12-31 | -148.05% |
| 2023-08-31 | -498.10% |
| 2023-06-30 | -2101.58% |
| 2023-03-31 | -606.87% |
| 2022-12-31 | -338.62% |
| 2022-09-30 | -326.06% |
| 2022-06-30 | -331.06% |
| 2022-03-31 | -15988.05% |
| 2021-12-31 | 41.81% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | -7402.67% |
| 2021-03-31 | -7402.67% |
| 2020-12-31 | -1.41% |
| 2020-09-30 | -411.51% |
| 2020-06-30 | -206.46% |
| 2020-03-31 | -206.46% |
| 2019-12-31 | -192.52% |
| 2019-09-30 | -192.52% |
| 2019-06-30 | -192.52% |
| 2019-03-31 | -192.52% |
